CancerFax
RADIATION THERAPY GUIDE

IMAGE-GUIDED RADIATION
THERAPY (IGRT)

A complete guide to IGRT โ€” how taking images at the treatment machine before every session ensures the radiation beam lands exactly where it should, allowing smaller margins, better organ protection, and higher tumour doses across all cancer types.

analyticsAt a Glance

  • check_circleIGRT is not a separate radiation type โ€” it is a daily imaging verification layer applied on top of IMRT, VMAT, SBRT, and proton therapy.
  • check_circleCone-beam CT before each session confirms tumour position and corrects for daily anatomical shifts before any radiation is delivered.
  • check_circleSmaller safety margins mean less healthy tissue in the high-dose zone โ€” fewer side effects and the ability to safely raise tumour dose.
  • check_circleAvailable at all major Chinese radiation oncology centres and throughout India's large private cancer hospital network.
Reviewed by: CancerFax Medical Team, Oncology & Haematology SpecialistsLast reviewed: June 4, 2026

What Is Image-Guided Radiation Therapy?

IGRT means taking images of the patient at the treatment machine itself โ€” right before each radiation session โ€” to confirm the tumour is in the expected position. If it has moved, the team corrects before delivering the dose. It turns radiotherapy from a plan made on one scan into treatment that is verified and corrected every single day.

โ€œIGRT shrinks the uncertainty in where the tumour is each day โ€” and that allows the safety margin to shrink too. Smaller margins mean less healthy tissue irradiated.โ€
  • Why Daily Imaging Matters

    The body is not a fixed object. Organs shift, patients lose weight, tumours shrink during treatment. Without daily imaging, large safety margins around the tumour are required to ensure it is always covered. IGRT confirms exact position each day, allowing margins to be reduced โ€” protecting more normal tissue.

  • Cone-Beam CT (CBCT) โ€” The Standard IGRT Tool

    A cone-beam CT acquired on the treatment machine provides a 3D image of the patient's anatomy in treatment position. The image is compared to the planning CT, shifts are measured, and the treatment couch is adjusted before radiation delivery. Takes 1-3 minutes. Used at most modern radiation centres globally.

  • Surface-Guided RT (SGRT) โ€” Contactless Monitoring

    Optical cameras map the patient's surface in 3D and monitor it continuously during treatment. Any movement triggers an alert or pauses the beam. Particularly useful for breath-hold techniques in breast cancer (protecting the heart) and for real-time monitoring during any IGRT session.

  • IGRT as a Layer on Top of Other Techniques

    IGRT is not a standalone treatment โ€” it is image guidance applied to IMRT, VMAT, SBRT, or proton therapy. Image-guided IMRT, image-guided SBRT, and image-guided proton therapy are all IGRT. The imaging confirms the advanced technique is being delivered to the right place.

IGRT by Cancer Site: Where It Makes the Most Difference

IGRT benefits virtually all cancer sites where radiotherapy is used. The following sites show the most clinically significant advantages.

  • Prostate Cancer

    The prostate moves substantially with rectal filling and bladder volume changes โ€” by up to 1-2 cm between sessions. Without IGRT, margins must account for this uncertainty. Daily CBCT or fiducial marker tracking confirms prostate position precisely before each fraction, allowing margins to be reduced from 1 cm to 3-5 mm and significantly reducing rectal and bladder toxicity.

  • Lung Cancer

    Lung tumours move with breathing โ€” sometimes by more than 1 cm. 4D-CT during planning characterises this motion. IGRT before each session confirms the tumour's average position and accounts for residual setup variability. Real-time motion management including gating and tracking further improves accuracy for moving targets.

  • Liver, Pancreas, and Upper Abdominal Tumours

    Liver tumours move substantially with breathing and the liver itself changes shape with variations in organ filling. For MR-LINAC-based treatment, daily adaptive re-planning accounts for these changes. For CBCT-guided SBRT, daily imaging and motion management enable safe dose escalation in sites previously limited by proximity to bowel and bile duct.

  • Head and Neck Cancer

    Patients lose weight and tumours shrink substantially during 6-7 weeks of head and neck chemoradiotherapy โ€” the neck literally changes shape. Daily IGRT detects anatomical change. Adaptive replanning (re-CT mid-treatment) corrects the plan for the new anatomy, preserving coverage of the primary target while protecting the spinal cord, salivary glands, and swallowing muscles.

  • Breast Cancer

    For left-sided breast cancer, surface-guided breath-hold techniques allow patients to hold a breath that pulls the heart away from the radiation field. Daily surface imaging confirms the breath-hold is consistent. This reduces mean heart dose and may significantly reduce long-term cardiac events 10-20 years after treatment.

IGRT Technologies Compared

Different imaging modalities are used for IGRT depending on the cancer site, tumour type, and available technology.

TechnologyImage TypeBest ForKey Limitation
Cone-Beam CT (CBCT)3D X-ray volumeMost sites โ€” prostate, lung, head and neck, pelvisLower soft tissue contrast than MRI; radiation dose from imaging
MRI-Guided (MR-LINAC)Real-time high-quality MRISoft tissue tumours with motion โ€” pancreas, prostate, liver, rectumLonger session time; limited centre availability; cost
Surface-Guided RT (SGRT)3D optical surface mapBreast breath-hold; whole-brain RT; monitoring during deliveryTracks surface, not internal tumour directly
Kilovoltage X-ray (2D)Planar X-ray imagesBony landmark verification; simple targetsPoor soft tissue contrast; 2D only
Ultrasound GuidanceReal-time ultrasoundProstate (transabdominal); liverOperator dependent; limited to superficial sites

What IGRT Achieves: Key Numbers

  • 50-70%Reduction in Planning Margin (Prostate, with IGRT)From 10-15 mm (no IGRT) to 3-5 mm โ€” directly reducing volume of rectum in the high-dose zone.
  • ~1-2 cmTypical Prostate Motion Between SessionsWithout daily IGRT, this uncertainty requires generous safety margins that irradiate more rectum and bladder.
  • DailyIGRT Imaging Frequency โ€” SBRT and SBRT-Like RegimensEvery session imaged before beam delivery โ€” mandatory for high-dose-per-fraction treatments.
  • ~100%Modern Cancer Centres Using IGRT for IMRT/VMATIGRT is now standard practice alongside IMRT and VMAT at well-equipped centres globally.

Frequently Asked Questions

About IGRT

  • Does IGRT add extra radiation dose beyond the treatment itself?

    CBCT imaging used for IGRT does deliver a small additional radiation dose โ€” typically 1-5% of the daily treatment dose, depending on the imaging protocol. This is considered clinically acceptable given the significant accuracy benefit. Centres use low-dose CBCT protocols to minimise imaging dose while maintaining adequate image quality for position verification.

  • Is IGRT available at cancer centres in China and India?

    Yes. IGRT is standard practice at all major cancer centres in both countries. Modern linear accelerators are equipped with cone-beam CT and, at leading centres, surface-guided RT systems and MRI-linac platforms. Fudan University Shanghai Cancer Center, Sun Yat-sen University Cancer Center, National Cancer Center Beijing, Tata Memorial Centre, Apollo Cancer Centres, and AIIMS all use IGRT as routine practice for IMRT, VMAT, and SBRT delivery.

  • What is the difference between IGRT and adaptive radiation therapy?

    IGRT verifies tumour position before each session and corrects setup errors. Adaptive radiation therapy (ART) goes further โ€” it modifies the treatment plan itself in response to changes in tumour size, shape, or anatomy over the treatment course. Both use imaging; ART uses that imaging to re-optimise the plan, while standard IGRT uses it to verify and correct the original plan. MR-LINAC enables online ART (same-day plan modification), the most advanced form of both IGRT and ART combined.

How CancerFax Helps

CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

description
Medical Record Review

We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

verified_user
Eligibility Coordination

We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

hub
Hospital Communication

We support appointment coordination, document submission, translation, and direct communication with international departments.

flight
Travel & Admission Support

For international patients, we help with practical coordination โ€” travel planning, hospital admission guidance, and local support.

explore
Treatment & Trial Navigation

If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

support_agent
End-to-end Coordination

From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

Exploring Advanced Radiotherapy for Your Diagnosis?

Upload your medical reports and imaging โ€” our radiation oncology team will review your case and help identify the right radiation technique and the best centre for your specific cancer.

This content is for informational purposes only and does not constitute medical advice. All treatment decisions must be made in consultation with a qualified radiation oncologist.